Memet Aker

8.3k total citations · 3 hit papers
69 papers, 5.7k citations indexed

About

Memet Aker is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Memet Aker has authored 69 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 15 papers in Immunology and 12 papers in Genetics. Recurrent topics in Memet Aker's work include Hematopoietic Stem Cell Transplantation (25 papers), Immune Cell Function and Interaction (12 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Memet Aker is often cited by papers focused on Hematopoietic Stem Cell Transplantation (25 papers), Immune Cell Function and Interaction (12 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Memet Aker collaborates with scholars based in Israel, United States and Italy. Memet Aker's co-authors include Shimon Slavin, Reuven Or, Arnon Nagler, Aliza Ackerstein, Simcha Samuel, Gàbor Varadi, Avraham Amar, Chaim Brautbar, Gabriel Cividalli and E Naparstek and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Memet Aker

68 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

1998 1.6k citations Shimon Slavin, Arnon Nagler et al. Blood profile →
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

1998 1.5k citations Shimon Slavin, Arnon Nagler et al. Blood profile →
Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning

2002 808 citations Alessandro Aiuti, Shimon Slavin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Memet Aker Israel	27	3.6k	1.7k	1.5k	1.3k	1.2k	69	5.7k
A. John Barrett United States	43	3.9k 1.1×	2.7k 1.6×	1.7k 1.1×	824 0.6×	457 0.4×	109	6.0k
Pablo Rubinstein United States	25	2.7k 0.7×	1.8k 1.1×	815 0.5×	968 0.7×	677 0.6×	61	4.9k
Richard A. Nash United States	48	4.9k 1.4×	2.7k 1.6×	1.6k 1.0×	833 0.6×	610 0.5×	176	7.8k
JH Kersey United States	42	4.5k 1.2×	2.8k 1.6×	1.9k 1.2×	1.2k 0.9×	517 0.4×	108	7.5k
B Speck Switzerland	36	4.8k 1.3×	2.3k 1.3×	1.5k 1.0×	456 0.3×	639 0.5×	200	6.4k
JM Goldman United Kingdom	31	6.1k 1.7×	2.7k 1.6×	1.7k 1.1×	657 0.5×	496 0.4×	83	7.4k
Jon J. van Rood Netherlands	42	2.5k 0.7×	3.5k 2.1×	896 0.6×	626 0.5×	618 0.5×	114	6.5k
Jürgen Kuball Netherlands	45	2.3k 0.6×	3.5k 2.0×	3.3k 2.1×	1.2k 0.9×	882 0.8×	175	6.8k
J.H. Frederik Falkenburg Netherlands	53	3.6k 1.0×	5.4k 3.2×	3.7k 2.4×	1.8k 1.4×	1.4k 1.2×	280	9.1k
Michele Cottler‐Fox United States	36	2.5k 0.7×	1.0k 0.6×	1.4k 0.9×	1.5k 1.1×	662 0.6×	140	4.2k

Countries citing papers authored by Memet Aker

Since Specialization

Citations

This map shows the geographic impact of Memet Aker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Memet Aker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Memet Aker more than expected).

Fields of papers citing papers by Memet Aker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Memet Aker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Memet Aker. The network helps show where Memet Aker may publish in the future.

Co-authorship network of co-authors of Memet Aker

This figure shows the co-authorship network connecting the top 25 collaborators of Memet Aker. A scholar is included among the top collaborators of Memet Aker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Memet Aker. Memet Aker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fibach, Eitan & Memet Aker. (2012). Hemin Augments Growth and Hemoglobinization of Erythroid Precursors from Patients with Diamond-Blackfan Anemia. Anemia. 2012. 1–4. 1 indexed citations

Selleri, Silvia, Immacolata Brigida, Miriam Casiraghi, et al.. (2011). In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency. Journal of Allergy and Clinical Immunology. 127(6). 1368–1375.e8. 8 indexed citations

Feigelson, Sara W., Valentin Grabovsky, Ronit Pasvolsky, et al.. (2011). Kindlin-3 is required for the stabilization of TCR-stimulated LFA-1:ICAM-1 bonds critical for lymphocyte arrest and spreading on dendritic cells. Blood. 117(26). 7042–7052. 46 indexed citations

Feigelson, Sara W., Ronit Pasvolsky, Memet Aker, et al.. (2009). Loss of Kindlin-3 in LAD-III eliminates LFA-1 but not VLA-4 adhesiveness developed under shear flow conditions. Blood. 114(11). 2344–2353. 82 indexed citations

Resnick, Igor, Memet Aker, Simcha Samuel, et al.. (2009). A Retrospective Review of the Outcome after Second or Subsequent Allogeneic Transplantation. Biology of Blood and Marrow Transplantation. 15(4). 483–489. 25 indexed citations

Lamm, Noa, et al.. (2009). Diminished Telomeric 3′ Overhangs Are Associated with Telomere Dysfunction in Hoyeraal-Hreidarsson Syndrome. PLoS ONE. 4(5). e5666–e5666. 31 indexed citations

Stern‐Ginossar, Noam, Shlomo Nedvetzki, Gal Markel, et al.. (2007). Intercellular Transfer of Carcinoembryonic Antigen from Tumor Cells to NK Cells. The Journal of Immunology. 179(7). 4424–4434. 13 indexed citations

Weintraub, Michael, et al.. (2007). Secondary Acute Myeloid Leukemia After Etoposide Therapy for Retinoblastoma. Journal of Pediatric Hematology/Oncology. 29(9). 646–648. 9 indexed citations

Aiuti, Alessandro, Barbara Cassani, Grazia Andolfi, et al.. (2007). Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy. Journal of Clinical Investigation. 117(8). 2233–2240. 180 indexed citations

10.

Shapira, Michael Y., Allan I. Bloom, Reuven Or, et al.. (2002). Intra‐arterial catheter directed therapy for severe graft‐versus‐host disease. British Journal of Haematology. 119(3). 760–764. 20 indexed citations

11.

Or, Reuven, Michael Y. Shapira, Igor Resnick, et al.. (2002). Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase. Blood. 101(2). 441–445. 151 indexed citations

12.

Nagler, Arnon, Memet Aker, Reuven Or, et al.. (2001). Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation. Experimental Hematology. 29(3). 362–370. 88 indexed citations

13.

Slavin, Shimon, Reuven Or, Memet Aker, et al.. (2001). Nonmyeloablative stem cell transplantation for the treatment of cancer and life-threatening nonmalignant disorders: past accomplishments and future goals. Cancer Chemotherapy and Pharmacology. 48(0). S79–S84. 14 indexed citations

14.

Slavin, Shimon, Arnon Nagler, Michael Y. Shapira, Memet Aker, & Reuven Or. (2000). Non-myeloablative allogeneic stem cell transplantation for the treatment of patients with chronic myeloid leukemia. 96. 6 indexed citations

15.

Rachmilewitz, Eliezer A. & Memet Aker. (1998). The Role of Recombinant Human Erythropoietin in the Treatment of Thalassemia. Annals of the New York Academy of Sciences. 850(1). 129–138. 39 indexed citations

16.

Or, Reuven, Joseph Kapelushnik, Elizabeth Naparstek, et al.. (1996). Second transplantation using allogeneic peripheral blood stem cells in a β‐thalassaemia major patient featuring stable mixed chimaerism. British Journal of Haematology. 94(2). 285–287. 12 indexed citations

17.

Aker, Memet & Huarong Huang. (1996). Extreme heterogeneity of minor satellite repeat arrays in inbred strains of mice. Mammalian Genome. 7(1). 62–64. 3 indexed citations

18.

Engelhard, Dan, Nurith Strauss, Abraham Morag, et al.. (1989). Cytomegalovirus infection and disease after T cell depleted allogeneic bone marrow transplantation for malignant hematologic diseases.. PubMed. 21(1 Pt 3). 3101–2. 8 indexed citations

19.

Amitai, Yona, et al.. (1985). Scorpion Sting in Children. Clinical Pediatrics. 24(3). 136–140. 61 indexed citations

20.

Perlman, Max, Memet Aker, & Alfred E. Slonim. (1979). Successful treatment of severe Type I glycogen storage disease with neonatal presentation by nocturnal intragastric feeding. The Journal of Pediatrics. 94(5). 772–774. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact